These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26987920)

  • 21. Nucleosome organizations in induced pluripotent stem cells reprogrammed from somatic cells belonging to three different germ layers.
    Tao Y; Zheng W; Jiang Y; Ding G; Hou X; Tang Y; Li Y; Gao S; Chang G; Zhang X; Liu W; Kou X; Wang H; Jiang C; Gao S
    BMC Biol; 2014 Dec; 12():109. PubMed ID: 25528259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-viral reprogramming of fibroblasts into induced pluripotent stem cells by Sleeping Beauty and piggyBac transposons.
    Talluri TR; Kumar D; Glage S; Garrels W; Ivics Z; Debowski K; Behr R; Kues WA
    Biochem Biophys Res Commun; 2014 Jul; 450(1):581-7. PubMed ID: 24928388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of human β-thalassemia induced pluripotent stem cells from amniotic fluid cells using a single excisable lentiviral stem cell cassette.
    Fan Y; Luo Y; Chen X; Li Q; Sun X
    J Reprod Dev; 2012; 58(4):404-9. PubMed ID: 22498813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of induced pluripotent stem cells from neonatal mouse cochlear cells.
    Du D; Lou X
    Differentiation; 2014; 87(3-4):127-33. PubMed ID: 24582575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induced pluripotent stem (iPS) cells from human fetal stem cells.
    Guillot PV
    Best Pract Res Clin Obstet Gynaecol; 2016 Feb; 31():112-20. PubMed ID: 26427551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reprogramming somatic cells into pluripotent stem cells using miRNAs.
    Anokye-Danso F
    Methods Mol Biol; 2014; 1150():273-81. PubMed ID: 24744006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Current progress and application prospects of induced pluripotent stem cells].
    Qin T; Miao XY
    Yi Chuan; 2010 Dec; 32(12):1205-14. PubMed ID: 21513145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired adipogenic capacity in induced pluripotent stem cells from lipodystrophic patients with BSCL2 mutations.
    Mori E; Fujikura J; Noguchi M; Nakao K; Matsubara M; Sone M; Taura D; Kusakabe T; Ebihara K; Tanaka T; Hosoda K; Takahashi K; Asaka I; Inagaki N; Nakao K
    Metabolism; 2016 Apr; 65(4):543-56. PubMed ID: 26975546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of iPSC lines from primary human amniotic fluid cells.
    Drews K; Matz P; Adjaye J
    Stem Cell Res; 2015 Nov; 15(3):712-4. PubMed ID: 26987930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reprogramming of somatic cells after fusion with induced pluripotent stem cells and nuclear transfer embryonic stem cells.
    Sumer H; Jones KL; Liu J; Heffernan C; Tat PA; Upton KR; Verma PJ
    Stem Cells Dev; 2010 Feb; 19(2):239-46. PubMed ID: 19637940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of reprogramming ability of mouse ES and iPS cells measured by somatic cell fusion.
    Sumer H; Nicholls C; Liu J; Tat PA; Liu JP; Verma PJ
    Int J Dev Biol; 2010; 54(11-12):1723-8. PubMed ID: 21404192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transient folate deprivation facilitates the generation of mouse-induced pluripotent stem cells.
    Yan Q; Xu J; Hu W; Li Z; Wu J; Zhang S
    Cell Biol Int; 2014 May; 38(5):571-6. PubMed ID: 24375975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modeling Andersen's Syndrome in Human Induced Pluripotent Stem Cells.
    Pini J; Rouleau M; Desnuelle C; Sacconi S; Bendahhou S
    Stem Cells Dev; 2016 Jan; 25(2):151-9. PubMed ID: 26573604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inducible Transgene Expression in Human iPS Cells Using Versatile All-in-One piggyBac Transposons.
    Kim SI; Oceguera-Yanez F; Sakurai C; Nakagawa M; Yamanaka S; Woltjen K
    Methods Mol Biol; 2016; 1357():111-31. PubMed ID: 26025620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Derivation of Equine-Induced Pluripotent Stem Cell Lines Using a piggyBac Transposon Delivery System and Temporal Control of Transgene Expression.
    Nagy K; Nagy A
    Methods Mol Biol; 2015; 1330():79-88. PubMed ID: 26621591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The timing of retroviral silencing correlates with the quality of induced pluripotent stem cell lines.
    Okada M; Yoneda Y
    Biochim Biophys Acta; 2011 Feb; 1810(2):226-35. PubMed ID: 20965232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variations in mesenchymal-epithelial transition-related transcription factors during reprogramming of somatic cells from different germ layers into iPSCs.
    Lu X; Wang Y; Yan L; Wang L; Li W; Wang H
    J Genet Genomics; 2016 Oct; 43(10):609-612. PubMed ID: 27756625
    [No Abstract]   [Full Text] [Related]  

  • 38. Reprogramming of mouse somatic cells into pluripotent stem-like cells using a combination of small molecules.
    Kang PJ; Moon JH; Yoon BS; Hyeon S; Jun EK; Park G; Yun W; Park J; Park M; Kim A; Whang KY; Koh GY; Oh S; You S
    Biomaterials; 2014 Aug; 35(26):7336-45. PubMed ID: 24881998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induced pluripotent stem cells from goat fibroblasts.
    Song H; Li H; Huang M; Xu D; Gu C; Wang Z; Dong F; Wang F
    Mol Reprod Dev; 2013 Dec; 80(12):1009-17. PubMed ID: 24123501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transposon-based reprogramming to induced pluripotency.
    Kumar D; Talluri TR; Anand T; Kues WA
    Histol Histopathol; 2015 Dec; 30(12):1397-409. PubMed ID: 26301418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.